Research & Development
Academic Report
High diagnostic performance of the random-access HISCL-5000 pTau217, Aβ42 and Aβ40 plasma assays for detecting amyloid pathology across the Alzheimer’s disease clinical continuum.
| Presented by: | Inge Verberk1), Daniel Antwi-Berko1), Thomas Claessen2), Hans Heijst1), Azzam Aladdin1), Yuko Sasaki Mori3), Roman Boeer4), Argonde van Harten2), Charlotte Teunissen1) |
| 1) Neurochemistry Laboratory, Laboratory Medicine, Amsterdam UMC 2) Alzheimer Center Amsterdam, Neurology, Amsterdam UMC 3) Sysmex R&D Center Europe GmbH 4) Sysmex Europe SE |
|
| Academic conference: |
18th Clinical Trials on Alzheimer's Disease (CTAD) |
| Presentation Date: | December 3, 2025 |
- Information contained in the academic report is current as of the date of the announcement,
but may be subject to change without prior notice.